Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Warm compress device shows promise for dry eyes before cataract surgery

NCT ID NCT06483750

Symptom relief Sponsor: George Washington University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether using the Systane iLux device—which applies heat and pressure to the eyelids—before cataract surgery could improve dry eye symptoms. Thirty adults scheduled for cataract surgery received the treatment in one eye. Researchers measured changes in tear film thickness and dry eye symptoms from before surgery to four weeks after.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Systane iLux thermal pulsation device
What this could lead to
If it works, this could provide a simple, in-office treatment to improve dry eye symptoms before cataract surgery, potentially improving surgical outcomes and patient comfort.
What could go wrong
This is a small, completed study with only 30 participants and no control group. Results may not apply to everyone, and the device may not work for all types of dry eye.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2024

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age greater than 18 at the time of informed consent * Must understand; be willing and able, and likely to fully comply with study procedures, visit schedule, and restrictions * Upcoming scheduled senile cataract surgery Exclusion Criteria: * Eyelid abnormalities * Patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months * Ocular surgery within the last 6 months * Occlusion therapy with lacrimal or punctum plugs within the last 3 months * Patients with an ocular surface abnormality that may compromise corneal integrity * Patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months) * Patients with cicatricial lid margin disease * patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia * Patients with permanent makeup or tattoos on their eyelids. * Previous application/administration of Systane iLux or LipiFlow treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cataract senile are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dry eye syndrome Meibomian Gland Dysfunction senile cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cataract senile Dry eye disease Dry eye syndromes Meibomian gland dysfunction

Contacts and locations

Locations

  • George Washington University

    Washington D.C., District of Columbia, 20037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.